Real-world prophylactic usage of recombinant factor IX Fc in Sweden : A report from the Swedish National Registry for bleeding disorders
Reply to Pandey: IgG3 allotypes, modulation of antigen binding by constant domain changes, and therapeutic applications of Fc engineering
ABO zygosity, but not secretor or Fc receptor status, is a significant risk factor for IVIG-Associated hemolysis
European and International Trade and Tax Law, Europeisk och internationell skatterätt - Magisterprogram
